- Home
- TMC vs VKTX Comparison
TMC vs VKTX Comparison
Compare TMC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMC
- VKTX
- Stock Information
- Founded
- TMC 2011
- VKTX 2012
- Country
- TMC Canada
- VKTX United States
- Employees
- TMC N/A
- VKTX N/A
- Industry
- TMC Metal Mining
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- TMC Basic Materials
- VKTX Health Care
- Exchange
- TMC Nasdaq
- VKTX Nasdaq
- Market Cap
- TMC 4.3B
- VKTX 3.8B
- IPO Year
- TMC N/A
- VKTX 2015
- Fundamental
- Price
- TMC $6.88
- VKTX $35.22
- Analyst Decision
- TMC Strong Buy
- VKTX Strong Buy
- Analyst Count
- TMC 4
- VKTX 14
- Target Price
- TMC $6.88
- VKTX $87.00
- AVG Volume (30 Days)
- TMC 13.1M
- VKTX 4.8M
- Earning Date
- TMC 11-13-2025
- VKTX 10-22-2025
- Dividend Yield
- TMC N/A
- VKTX N/A
- EPS Growth
- TMC N/A
- VKTX N/A
- EPS
- TMC N/A
- VKTX N/A
- Revenue
- TMC N/A
- VKTX N/A
- Revenue This Year
- TMC N/A
- VKTX N/A
- Revenue Next Year
- TMC N/A
- VKTX N/A
- P/E Ratio
- TMC N/A
- VKTX N/A
- Revenue Growth
- TMC N/A
- VKTX N/A
- 52 Week Low
- TMC $0.72
- VKTX $18.92
- 52 Week High
- TMC $11.35
- VKTX $79.10
- Technical
- Relative Strength Index (RSI)
- TMC 43.67
- VKTX 60.22
- Support Level
- TMC $6.64
- VKTX $33.00
- Resistance Level
- TMC $7.54
- VKTX $36.11
- Average True Range (ATR)
- TMC 0.81
- VKTX 2.02
- MACD
- TMC -0.33
- VKTX 0.09
- Stochastic Oscillator
- TMC 5.10
- VKTX 73.40
About TMC TMC the metals company Inc.
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.